Nobuhiko Nakamura

17PUBLICATIONS
61CO-AUTHORS
Haematological tumoursAutoimmunityMedical infection agents (incl. prions)Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 30, 2026
Tracheostomy Before Polatuzumab Vedotin-Containing Therapy for Airway-Threatening Cervical Diffuse Large B-Cell Lymphoma: A Case Report of Two Patients.

|Aug 11, 2026
HIV-Associated Diffuse Large B-Cell Lymphoma Treated With Outpatient Pola-R-CHP Without Antiretroviral Therapy Modification: A Case Report.

|Jul 29, 2026
Longitudinal changes in laboratory parameters and QTc during isavuconazole therapy in Japanese patients with hematologic malignancies.

|Apr 09, 2026
Treatment and outcomes of pulmonary mucosa-associated lymphoid tissue lymphoma: A multicenter analysis of 186 patients.

Kazutaka Suzuki, Kana Miyazaki, Naoko Asano

|Nov 27, 2025
Donor-Derived T-Cell Redirection With Epcoritamab Achieving Complete Response After Early Post-Allo-HSCT Relapse of DLBCL.

Yoshikazu Ikoma, Yuto Kaneda, Ryoma Shimazu

|Oct 09, 2025
Polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) therapy in diffuse large B-cell lymphoma in patients aged 80 years or older: a real-world study.

Toshiki Yamada, Nobuhiko Nakamura, Hideko Goto

Pageof 3

Frequent Collaborators

7 joint publications

Nobuhiro Kanemura

6 joint publications

Yoshikazu Ikoma

3 joint publications

Masahito Shimizu

3 joint publications

Akifumi Takaori-Kondo